{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:52:56Z","timestamp":1758477176803,"version":"3.40.5"},"reference-count":77,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Republic of Turkey, Ministry of Development","award":["2016 K121190"],"award-info":[{"award-number":["2016 K121190"]}]}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jfda.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T13:51:35Z","timestamp":1538142695000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel technologies in detection, treatment and prevention of substance use disorders"],"prefix":"10.38212","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3934-6415","authenticated-orcid":false,"given":"Hichem","family":"Moulahoum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"Zihnioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suna","family":"Timur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Coskunol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25385","reference":[{"issue":"9904","key":"10.1016\/j.jfda.2018.09.003_bib1","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jfda.2018.09.003_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1517\/14712598.2013.791278","article-title":"Can you vaccinate against substance abuse?","volume":"13","author":"Kosten","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.jfda.2018.09.003_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/erv.13.1","article-title":"Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse","volume":"12","author":"Brimijoin","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.jfda.2018.09.003_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1441.027","article-title":"Substance abuse vaccines","volume":"1141","author":"Orson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"48","key":"10.1016\/j.jfda.2018.09.003_bib6","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1016\/j.vaccine.2015.09.079","article-title":"Is immunotherapy an opportunity for effective treatment of drug addiction?","volume":"33","author":"Zalewska-Kaszubska","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jfda.2018.09.003_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/icb.2009.17","article-title":"Anti-drug vaccines to treat substance abuse","volume":"87","author":"Kinsey","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jfda.2018.09.003_bib8","series-title":"International review of neurobiology","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.irn.2016.02.009","article-title":"Animal models and the development of vaccines to treat substance use disorders","author":"Ohia-Nwoko","year":"2016"},{"issue":"42","key":"10.1016\/j.jfda.2018.09.003_bib9","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.vaccine.2014.07.085","article-title":"Adjuvants for vaccines to drugs of abuse and addiction","volume":"32","author":"Alving","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nri3130","article-title":"Vaccines targeting drugs of abuse: is the glass half-empty or half-full?","volume":"12","author":"Janda","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.jfda.2018.09.003_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/2051013614537818","article-title":"Vaccines against drugs of abuse: where are we now?","volume":"2","author":"Kinsey","year":"2014","journal-title":"Ther Adv Vaccines"},{"issue":"2","key":"10.1016\/j.jfda.2018.09.003_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bcp.12115","article-title":"Vaccines against stimulants: cocaine and MA","volume":"77","author":"Kosten","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.jfda.2018.09.003_bib13","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1021\/ja400356g","article-title":"Modulating cocaine vaccine potency through hapten fluorination","volume":"135","author":"Cai","year":"2013","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.jfda.2018.09.003_bib14","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/mp400214w","article-title":"Probing the effects of hapten stability on cocaine vaccine immunogenicity","volume":"10","author":"Cai","year":"2013","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.jfda.2018.09.003_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/bc500016k","article-title":"Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse","volume":"25","author":"Collins","year":"2014","journal-title":"Bioconjug Chem"},{"issue":"22","key":"10.1016\/j.jfda.2018.09.003_bib16","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","article-title":"Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines","volume":"27","author":"Duryee","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jfda.2018.09.003_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/ajad.12307","article-title":"Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine","volume":"24","author":"Haile","year":"2015","journal-title":"Am J Addict"},{"issue":"26","key":"10.1016\/j.jfda.2018.09.003_bib18","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1567-5769(02)00260-6","article-title":"Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant","volume":"3","author":"Sanderson","year":"2003","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.jfda.2018.09.003_bib20","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.4049\/jimmunol.1500385","article-title":"The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse","volume":"194","author":"Laudenbach","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jfda.2018.09.003_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096547","article-title":"Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jfda.2018.09.003_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2014.01.010","article-title":"Hapten-specific naive B cells are biomarkers of vaccine efficacy against drugs of abuse","volume":"405","author":"Taylor","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jfda.2018.09.003_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.06.014","article-title":"Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats","volume":"153","author":"Miller","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.jfda.2018.09.003_bib24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","article-title":"A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats","volume":"73","author":"Miller","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"41","key":"10.1016\/j.jfda.2018.09.003_bib25","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1016\/j.vaccine.2013.07.038","article-title":"Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food","volume":"31","author":"Ruedi-Bettschen","year":"2013","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.jfda.2018.09.003_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"Shen","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.jfda.2018.09.003_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Broker","year":"2011","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.jfda.2018.09.003_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/mp500520r","article-title":"Flagellin as Carrier and adjuvant in cocaine vaccine development","volume":"12","author":"Lockner","year":"2015","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.jfda.2018.09.003_bib29","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/npp.2013.114","article-title":"Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter","volume":"38","author":"Maoz","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jfda.2018.09.003_bib30","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1080\/21645515.2016.1212785","article-title":"Biologics to treat substance use disorders: current status and new directions","volume":"12","author":"Pravetoni","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"Suppl 2","key":"10.1016\/j.jfda.2018.09.003_bib31","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.vaccine.2015.01.088","article-title":"New generation adjuvants--from empiricism to rational design","volume":"33","author":"O'Hagan","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jfda.2018.09.003_bib32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.1402604","article-title":"Oil-in-water emulsion MF59 increases germinal center B cell differentiation and persistence in response to vaccination","volume":"195","author":"Lofano","year":"2015","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jfda.2018.09.003_bib33","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.4049\/jimmunol.1402071","article-title":"MF59 mediates its B cell adjuvanticity by promoting T follicular helper cells and thus germinal center responses in adult and early life","volume":"194","author":"Mastelic Gavillet","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2013.03.021","article-title":"Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates","volume":"16","author":"McCluskie","year":"2013","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jfda.2018.09.003_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.intimp.2015.09.012","article-title":"Anti-nicotine vaccines: comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates","volume":"29","author":"McCluskie","year":"2015","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1016\/j.jfda.2018.09.003_bib36","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"10.1016\/j.jfda.2018.09.003_bib37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vaccine.2012.10.069","article-title":"High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants","volume":"31","author":"Chen","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jfda.2018.09.003_bib39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1574-695X.2006.00097.x","article-title":"Addictive drugs and their relationship with infectious diseases","volume":"47","author":"Friedman","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"10.1016\/j.jfda.2018.09.003_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S1461145707008097","article-title":"New treatments for cocaine dependence: a focused review","volume":"11","author":"Karila","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.jfda.2018.09.003_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1369-1600.2007.00061.x","article-title":"New developments in the pharmacotherapy of cocaine abuse","volume":"12","author":"Preti","year":"2007","journal-title":"Addict Biol"},{"issue":"4","key":"10.1016\/j.jfda.2018.09.003_bib42","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.98.4.1988","article-title":"A second-generation vaccine protects against the psychoactive effects of cocaine","volume":"98","author":"Carrera","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.jfda.2018.09.003_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1096-1129","article-title":"Efficacy of a therapeutic cocaine vaccine in rodent models","volume":"2","author":"Fox","year":"1996","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jfda.2018.09.003_bib44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jat\/26.7.382","article-title":"Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration","volume":"26","author":"Jenkins","year":"2002","journal-title":"J Anal Toxicol"},{"issue":"1\u20132","key":"10.1016\/j.jfda.2018.09.003_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2005.10.017","article-title":"Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues","volume":"309","author":"Danger","year":"2006","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.107.134395","article-title":"Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine","volume":"325","author":"Peterson","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"10.1016\/j.jfda.2018.09.003_bib47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.forsciint.2009.10.012","article-title":"Evaluation of on-site oral fluid screening using drugwipe-5(+), RapidSTAT and drug test 5000 for the detection of drugs of abuse in drivers","volume":"198","author":"Wille","year":"2010","journal-title":"Forensic Sci Int"},{"issue":"Pt 2","key":"10.1016\/j.jfda.2018.09.003_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/000456329503200203","article-title":"Screening for drugs of abuse. I: opiates, amphetamines and cocaine","volume":"32","author":"Braithwaite","year":"1995","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/abio.2001.5105","article-title":"Detection of analytes by immunoassay using up-converting phosphor technology","volume":"293","author":"Niedbala","year":"2001","journal-title":"Anal Biochem"},{"issue":"13","key":"10.1016\/j.jfda.2018.09.003_bib50","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1080\/00032710008543210","article-title":"Applications and recent developments in the use of antibodies for analysis","volume":"33","author":"Fitzpatrick","year":"2000","journal-title":"Anal Lett"},{"key":"10.1016\/j.jfda.2018.09.003_bib51","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.snb.2014.10.131","article-title":"A novel ultrasensitive aptasensor based on silver nanoparticles measured via enhanced voltammetric response of electrochemical reduction of riboflavin as redox probe for cocaine detection","volume":"207","author":"Roushani","year":"2015","journal-title":"Sens Actuators B Chem"},{"key":"10.1016\/j.jfda.2018.09.003_bib52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.talanta.2016.09.042","article-title":"Polypeptide with electroactive endgroups as sensing platform for the abused drug 'methamphetamine' by bioelectrochemical method","volume":"161","author":"Demir","year":"2016","journal-title":"Talanta"},{"issue":"7","key":"10.1016\/j.jfda.2018.09.003_bib53","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/acs.analchem.6b00760","article-title":"Polypeptide functional surface for the aptamer immobilization: electrochemical cocaine biosensing","volume":"88","author":"Bozokalfa","year":"2016","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.jfda.2018.09.003_bib54","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/dta.1992","article-title":"An aptamer folding-based sensory platform decorated with nanoparticles for simple cocaine testing","volume":"9","author":"Guler","year":"2017","journal-title":"Drug Test Anal"},{"issue":"21","key":"10.1016\/j.jfda.2018.09.003_bib55","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1039\/C7PY00420F","article-title":"Double fluorescence assay via a \u03b2-cyclodextrin containing conjugated polymer as a biomimetic material for cocaine sensing","volume":"8","author":"Arslan","year":"2017","journal-title":"Polym Chem"},{"issue":"2\u20133","key":"10.1016\/j.jfda.2018.09.003_bib56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.forsciint.2007.03.034","article-title":"Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing","volume":"170","author":"Concheiro","year":"2007","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/FTD.0b013e3181947916","article-title":"Evaluation of the Cozart DDSV test for cannabis in oral fluid","volume":"31","author":"Kintz","year":"2009","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib58","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jfda.2017.01.001","article-title":"Urine specimen validity test for drug abuse testing in workplace and court settings","volume":"26","author":"Lin","year":"2018","journal-title":"J Food Drug Anal"},{"issue":"3","key":"10.1016\/j.jfda.2018.09.003_bib59","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/15433714.2013.857178","article-title":"The effectiveness of electronic approaches to substance abuse prevention for adolescents","volume":"12","author":"Hopson","year":"2015","journal-title":"J Evid Inf Soc Work"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/0887044031000141199","article-title":"Interventions to change health behaviours: evidence-based or evidence-inspired?","volume":"19","author":"Michie","year":"2004","journal-title":"Psychol Health"},{"issue":"3","key":"10.1016\/j.jfda.2018.09.003_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10550887.2012.694606","article-title":"Leveraging technology to enhance addiction treatment and recovery","volume":"31","author":"Marsch","year":"2012","journal-title":"J Addict Dis"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/10826084.2011.521423","article-title":"Application of technology in the prevention and treatment of substance use disorders and related problems: opportunities and challenges","volume":"46","author":"Copeland","year":"2011","journal-title":"Subst Use Misuse"},{"issue":"5","key":"10.1016\/j.jfda.2018.09.003_bib63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jadohealth.2016.01.008","article-title":"Impact of a mobile e-health intervention on binge drinking in young people: the digital-alcohol risk alertness notifying network for adolescents and young adults project","volume":"58","author":"Carra","year":"2016","journal-title":"J Adolesc Health Off Publ Soc Adolesc Med"},{"key":"10.1016\/j.jfda.2018.09.003_bib64","article-title":"Mobile phone-based interventions for smoking cessation","volume":"4","author":"Whittaker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jfda.2018.09.003_bib65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chc.2016.06.005","article-title":"Technology-based interventions for preventing and treating substance use among youth","volume":"25","author":"Marsch","year":"2016","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"2\u20134","key":"10.1016\/j.jfda.2018.09.003_bib66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/15228830802094429","article-title":"A comprehensive review and a meta-analysis of the effectiveness of internet-based psychotherapeutic interventions","volume":"26","author":"Barak","year":"2008","journal-title":"J Technol Hum Serv"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1037\/a0015153","article-title":"Advancing the practice of online psychotherapy: an application of Rogers' diffusion of innovations theory","volume":"46","author":"Lovejoy","year":"2009","journal-title":"Psychotherapy (Chicago, Ill.)"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12160-009-9130-7","article-title":"Defining internet-supported therapeutic interventions","volume":"38","author":"Barak","year":"2009","journal-title":"Ann Behav Med: Publ Soc Behav Med"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1891\/0889-8391.26.1.43","article-title":"Clinical interventions for technology-based problems: excessive internet and video game use","volume":"26","author":"King","year":"2012","journal-title":"J Cogn Psychother"},{"key":"10.1016\/j.jfda.2018.09.003_bib70","first-page":"13","article-title":"The internet and drug markets: shining a light on these complex and dynamic systems, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","volume":"21","author":"Mounteney","year":"2016","journal-title":"Insights"},{"issue":"20","key":"10.1016\/j.jfda.2018.09.003_bib71","first-page":"20","article-title":"On the slow diffusion of point-of-care systems in therapeutic drug monitoring","volume":"3","author":"Sanavio","year":"2015","journal-title":"Front Bioeng Biotechnol"},{"issue":"7\u20138","key":"10.1016\/j.jfda.2018.09.003_bib72","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: safety and immunogenicity","volume":"20","author":"Kosten","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.jfda.2018.09.003_bib73","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.jfda.2018.09.003_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2009.08.031","article-title":"Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans","volume":"67","author":"Haney","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"6558","key":"10.1016\/j.jfda.2018.09.003_bib75","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jfda.2018.09.003_bib76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1567-5769(00)00019-9","article-title":"Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats","volume":"1","author":"Byrnes-Blake","year":"2001","journal-title":"Int Immunopharmacol"},{"issue":"17","key":"10.1016\/j.jfda.2018.09.003_bib77","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1021\/ja108807j","article-title":"Impact of distinct chemical structures for the development of a methamphetamine vaccine","volume":"133","author":"Moreno","year":"2011","journal-title":"J Am Chem Soc"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949818301522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949818301522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949818301522?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T18:19:42Z","timestamp":1666635582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1021949818301522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1021949818301522"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2018.09.003","relation":{},"ISSN":["1021-9498"],"issn-type":[{"type":"print","value":"1021-9498"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel technologies in detection, treatment and prevention of substance use disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}